Gestational Diabetes Mellitus per Different Diagnostic Criteria, Risk Factors, Obstetric Outcomes and Postpartum Glycemia: A Prospective Study in Ghana.
Ghana
blood glucose
gestational diabetes mellitus
hyperglycemia in pregnancy
newborn
postpartum period
pregnancy
pregnancy outcome
prevalence
risk factors
Journal
Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282
Informations de publication
Date de publication:
07 May 2021
07 May 2021
Historique:
received:
23
03
2021
revised:
17
04
2021
accepted:
20
04
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
The surge in gestational diabetes mellitus (GDM) globally requires a health system tailored approach towards prevention, detection and management. We estimated the prevalence of GDM using diverse recommended tests and diagnostic thresholds, and also assessed the risk factors and obstetric outcomes, including postpartum glycemia. Using a prospective cohort design, 446 singleton pregnant women without pre-existing diabetes did GDM tests in five hospitals in Ghana from 20-34 weeks using fasting plasma glucose (FPG), one-hour and 2-h oral glucose tolerance test (OGTT). Birth outcomes of 403 were assessed. GDM was diagnosed using six international diagnostic criteria. At 12 weeks postpartum, impaired fasting glucose (6.1-6.9 mmol/L) and diabetes (FPG ≥7.0 mmol/L) were measured for 100 women. Per FPG and 2-h OGTT cut-offs, GDM prevalence ranged between 8.3-23.8% and 4.4-14.3%, respectively. Risk factors included overweight (OR = 2.13, 95% CI: 1.13-4.03), previous miscarriage (OR = 4.01, 95% CI: 1.09-14.76) and high caloric intake (OR = 2.91, 95% CI: 1.05-8.07). Perineal tear (RR = 2.91, 95% CI: 1.08-5.57) and birth asphyxia (RR = 3.24, 95% CI: 1.01-10.45) were the associated perinatal outcomes. At 12 weeks postpartum, 15% had impaired fasting glucose, and 5% had diabetes. Tackling modifiable risk factors is crucial for prevention. Glycemic monitoring needs to be integral in postpartum and well-child reviews.
Identifiants
pubmed: 34066909
pii: clinpract11020039
doi: 10.3390/clinpract11020039
pmc: PMC8161461
doi:
Types de publication
Journal Article
Langues
eng
Pagination
257-271Références
Lancet Diabetes Endocrinol. 2017 Nov;5(11):924
pubmed: 28784318
BMJ. 2014 Mar 11;348:g1567
pubmed: 24618099
Afr Health Sci. 2018 Sep;18(3):743-755
pubmed: 30603008
S Afr Med J. 2017 May 24;107(6):523-527
pubmed: 28604326
Can J Diabetes. 2018 Apr;42 Suppl 1:S1-S5
pubmed: 29650079
Food Nutr Res. 2017 Jul 6;61(1):1341809
pubmed: 28747862
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
PLoS One. 2018 Dec 28;13(12):e0209322
pubmed: 30592751
Arch Public Health. 2019 Aug 6;77:36
pubmed: 31402976
BMC Pregnancy Childbirth. 2015 Feb 03;15:11
pubmed: 25643857
Arch Public Health. 2014 Oct 27;72(1):37
pubmed: 25671110
Obstet Gynecol. 2018 Feb;131(2):e49-e64
pubmed: 29370047
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
PLoS One. 2015 May 06;10(5):e0125712
pubmed: 25945500
Int J Gynaecol Obstet. 2015 Dec;131(3):246-50
pubmed: 26321217
Diabetes Care. 2015 Jan;38 Suppl:S8-S16
pubmed: 25537714
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Trop Med Int Health. 2018 Feb;23(2):236-242
pubmed: 29178236
Br J Gen Pract. 2018 Apr;68(669):172-173
pubmed: 29592924
Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:27-32
pubmed: 25855324
Trop Med Int Health. 2015 Aug;20(8):983-1002
pubmed: 25877657
Int J Gynaecol Obstet. 2015 Oct;131 Suppl 3:S173-S211
pubmed: 29644654
World J Diabetes. 2015 Jul 25;6(8):1065-72
pubmed: 26240703
BJOG. 2020 Jan;127(1):123
pubmed: 31654609
BMC Pregnancy Childbirth. 2012 Mar 31;12:23
pubmed: 22462760
Nutr Health. 2018 Dec;24(4):241-249
pubmed: 30092704
Diabetologia. 2011 Jul;54(7):1670-5
pubmed: 21494772
Diabetes Res Clin Pract. 2018 May;139:278-287
pubmed: 29526682
J Clin Med. 2018 May 28;7(6):
pubmed: 29843401